Literature DB >> 35152995

Generation of CAR T-cells using γ-retroviral vector.

Norihiro Watanabe1, Mary Kathryn McKenna2.   

Abstract

The generation of chimeric antigen receptor (CAR) T cells requires the transfer of the CAR gene into primary T cells. Among various gene transfer strategies, gammaretroviral vectors have been widely used to generate CAR T cells for both preclinical and clinical settings. Here we describe the detailed method of generating CAR T cells utilizing gammaretroviral vectors. This approach consists of two parallel parts: (1) production of the gammaretroviral particles and (2) gammaretroviral transduction of activated T cells. The gammaretroviral particles are produced by co-transfecting the gammaretroviral vector with packaging plasmids into 293T cells. The manufactured viral particles then efficiently infect activated T cells where the CAR transgene is integrated into host genomic DNA, resulting in stable expression of the CAR molecule on the surface of T cells.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chimeric antigen receptors; Gammaretroviral vectors; T cell transduction

Mesh:

Substances:

Year:  2021        PMID: 35152995      PMCID: PMC8917789          DOI: 10.1016/bs.mcb.2021.06.014

Source DB:  PubMed          Journal:  Methods Cell Biol        ISSN: 0091-679X            Impact factor:   1.441


  17 in total

1.  An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene.

Authors:  D A Persons; M G Mehaffey; M Kaleko; A W Nienhuis; E F Vanin
Journal:  Blood Cells Mol Dis       Date:  1998-06       Impact factor: 3.039

Review 2.  Non-viral vectors for gene-based therapy.

Authors:  Hao Yin; Rosemary L Kanasty; Ahmed A Eltoukhy; Arturo J Vegas; J Robert Dorkin; Daniel G Anderson
Journal:  Nat Rev Genet       Date:  2014-07-15       Impact factor: 53.242

3.  Highly efficient gene transfer into cord blood nonobese diabetic/severe combined immunodeficiency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein.

Authors:  P F Kelly; J Vandergriff; A Nathwani; A W Nienhuis; E F Vanin
Journal:  Blood       Date:  2000-08-15       Impact factor: 22.113

4.  Adoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-specific chimeric immune receptor in ovarian cancer xenograft model.

Authors:  S H Yoon; J M Lee; H I Cho; E K Kim; H S Kim; M Y Park; T G Kim
Journal:  Cancer Gene Ther       Date:  2008-12-19       Impact factor: 5.987

5.  Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.

Authors:  Shannon L Maude; Theodore W Laetsch; Jochen Buechner; Susana Rives; Michael Boyer; Henrique Bittencourt; Peter Bader; Michael R Verneris; Heather E Stefanski; Gary D Myers; Muna Qayed; Barbara De Moerloose; Hidefumi Hiramatsu; Krysta Schlis; Kara L Davis; Paul L Martin; Eneida R Nemecek; Gregory A Yanik; Christina Peters; Andre Baruchel; Nicolas Boissel; Francoise Mechinaud; Adriana Balduzzi; Joerg Krueger; Carl H June; Bruce L Levine; Patricia Wood; Tetiana Taran; Mimi Leung; Karen T Mueller; Yiyun Zhang; Kapildeb Sen; David Lebwohl; Michael A Pulsipher; Stephan A Grupp
Journal:  N Engl J Med       Date:  2018-02-01       Impact factor: 91.245

6.  Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent.

Authors:  Diogo Gomes-Silva; Malini Mukherjee; Madhuwanti Srinivasan; Giedre Krenciute; Olga Dakhova; Yueting Zheng; Joaquim M S Cabral; Cliona M Rooney; Jordan S Orange; Malcolm K Brenner; Maksim Mamonkin
Journal:  Cell Rep       Date:  2017-10-03       Impact factor: 9.423

Review 7.  Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics.

Authors:  M A Kay; J C Glorioso; L Naldini
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

Review 8.  Gammaretroviral vectors: biology, technology and application.

Authors:  Tobias Maetzig; Melanie Galla; Christopher Baum; Axel Schambach
Journal:  Viruses       Date:  2011-06-03       Impact factor: 5.048

Review 9.  Genetic Modification of T Cells.

Authors:  Richard A Morgan; Benjamin Boyerinas
Journal:  Biomedicines       Date:  2016-04-20

Review 10.  Clinical manufacturing of CAR T cells: foundation of a promising therapy.

Authors:  Xiuyan Wang; Isabelle Rivière
Journal:  Mol Ther Oncolytics       Date:  2016-06-15       Impact factor: 7.200

View more
  1 in total

Review 1.  Impact of Manufacturing Procedures on CAR T Cell Functionality.

Authors:  Norihiro Watanabe; Feiyan Mo; Mary Kathryn McKenna
Journal:  Front Immunol       Date:  2022-04-13       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.